Financial Altruism May Indicate Cognitive Decline in Seniors
WEDNESDAY, June 22, 2022 (HealthDay News) -- There is a negative relationship between financial altruism and cognitive functioning in older adults, according to a study published online June 13 in the Journal of Alzheimer's Disease.
Gali H. Weissberger, Ph.D., from Bar-Ilan University in Ramat Gan, Israel, and colleagues investigated the cognitive correlates of financial altruism (measured using an altruistic choice paradigm) among a community-based sample of 67 older adults (58.2 percent women). Participants completed a neuropsychological assessment and an altruistic choice paradigm, in which they were asked to make a choice between allocating money to themselves or an anonymous person.
The researchers found that when controlling for age, education, and sex, financial altruism was negatively associated with performance on cognitive measures typically sensitive to early Alzheimer disease, including word list learning and recall, delayed story recall, and animal fluency.
"Our goal is to understand why some older adults might be more susceptible than others to scam, fraud, or financial exploitation," a coauthor said in a statement. "Trouble handling money is thought to be one of the early signs of Alzheimer’s disease, and this finding supports that notion."
One author disclosed being a consultant for the AARP Staying Sharp program.
Abstract/Full Text (subscription or payment may be required)
Related Posts
No hay señales de que un esteroide común, la espironolactona, pueda provocar cáncer, según un estudio
JUEVES, 10 de marzo de 2022 (HealthDay News) -- La espironolactona, un esteroide...
Los aminoácidos asociados con la vitamina B se vinculan con la demencia por la contaminación atmosférica
VIERNES, 21 de julio de 2023 (HealthDay News) -- Los científicos han reportado...
Health Highlights: Oct. 27, 2022
Deadly aneurysm-linked strokes are on the rise. Subarachnoid hemorrhage strokes...
Kids Living Near Airports Face Lead Poisoning Dangers
WEDNESDAY, Jan. 11, 2023 (HealthDay News) -- While U.S. policymakers have...